Insulin Resistance
Insulin resistance is a state of reduced biological responsiveness to insulin and contributes to the development of several metabolic disorders, including type 2 diabetes.

What Does It Actually Mean?
Insulin resistance is a state of reduced biological responsiveness to insulin and contributes to the development of several metabolic disorders, including type 2 diabetes.
But to understand what it means for a tissue to become less responsive to insulin, we first need to consider what this hormone does under normal physiological conditions.
Insulin is a peptide hormone produced by the beta cells of the pancreas. Its secretion increases after a meal, especially as blood glucose levels rise.
Its role extends far beyond lowering blood glucose. Insulin helps coordinate how different tissues use and store nutrients.
What Happens After a Meal?
After a meal, some of the glucose released during carbohydrate digestion enters the bloodstream. The rise in blood glucose stimulates insulin secretion from the pancreas.
Different tissues respond in different ways.
In skeletal muscle, insulin stimulates glucose uptake and promotes its storage as glycogen.
In the liver, it helps suppress glucose production. This is particularly important after a meal, when glucose is already entering the circulation from the gut.
In adipose tissue, insulin suppresses lipolysis—the breakdown of stored triglycerides and the release of fatty acids.
This is a coordinated metabolic response, not an effect on a single organ or process.
It is in this broader context that the concept of insulin sensitivity becomes meaningful.
When the Response to Insulin Weakens
Insulin sensitivity describes how strongly a given tissue—or the body as a whole—responds to insulin.
In insulin resistance, a given concentration of insulin elicits a weaker biological response.
This does not mean that insulin has stopped working altogether.
Nor does it mean that all tissues lose sensitivity at the same time or to the same degree.
In muscle, insulin-stimulated glucose utilization may be reduced. In the liver, insulin may be less effective at suppressing glucose production. In adipose tissue, the suppression of lipolysis may be impaired.
As a result, insulin resistance in one tissue can alter the metabolic environment in which other tissues function.
The current picture is therefore more complex than a single impaired signal in a single location.
The Pancreas Can Compensate
Reduced insulin sensitivity does not necessarily cause blood glucose to rise immediately.
The pancreatic beta cells can increase insulin secretion.
If this compensation is sufficient, the higher insulin concentration can keep blood glucose within the normal range for a time.
This is why insulin resistance and high blood glucose are not the same thing.
The metabolic system may already be functioning differently even while glucose levels show no obvious abnormality.
Over time, the beta cells’ capacity to compensate becomes increasingly important.
Insulin resistance is a central feature of type 2 diabetes, but the development of hyperglycemia is also linked to insufficient beta-cell function relative to metabolic demands.
How Does Insulin Resistance Develop?
There is no single universal cause.
Genetic predisposition, body composition, the distribution of adipose tissue, physical activity, and a range of cellular and metabolic processes may all contribute to its development.
The relationship between impaired insulin sensitivity and lipid metabolism in the liver and skeletal muscle has been studied particularly extensively.
Lipid accumulation outside adipose tissue is often associated with insulin resistance.
But the amount of stored fat alone is not enough to explain this relationship.
One instructive example shows why.
The Athlete’s Paradox
In 2001, Goodpaster and colleagues published a study in The Journal of Clinical Endocrinology & Metabolism that revealed an apparently contradictory result.
Among people with insulin resistance, higher lipid content in skeletal muscle is generally associated with lower insulin sensitivity.
Yet endurance-trained athletes can also have high lipid content within muscle cells—and remain highly insulin sensitive.
The observation became known as the “athlete’s paradox.”
The phenomenon has proved more than a historical curiosity.
In 2024, a study published in Nature Communications revisited the paradox by comparing 29 male endurance-trained athletes with 30 people with type 2 diabetes.
Both groups can have increased amounts of lipid within muscle cells, but the physiological contexts are markedly different.
In athletes, muscle is adapted to storing and using lipids as an energy substrate, while insulin sensitivity remains high.
The question, then, is not simply how much fat the muscle contains.
What matters are the nature and location of the lipid stores, how the cell handles fatty acids, and the metabolic context in which the accumulation occurs.
This is why the simple claim that “fat in muscle causes insulin resistance” does not adequately describe the physiology.
It’s Not Just About Sugar
A similar oversimplification occurs when insulin resistance is explained solely in terms of sugar or carbohydrate consumption.
Diet matters for metabolic health, and a sustained energy surplus may contribute to the development of insulin resistance.
But the condition does not arise simply because the body has repeatedly secreted insulin in response to carbohydrate-containing meals.
Body composition, the distribution of adipose tissue, genetic predisposition, physical activity, and other physiological factors can all influence insulin sensitivity.
No single food or macronutrient is therefore enough to explain the condition as a whole.
How Is Insulin Sensitivity Measured?
Insulin resistance is not a single value that can be measured directly in the blood.
One of the reference methods used in research to assess insulin sensitivity is the hyperinsulinemic-euglycemic clamp.
In this procedure, insulin concentrations are raised in a controlled manner while glucose is infused to keep the blood glucose concentration approximately constant.
The amount of glucose needed to maintain this state provides a measure of the body’s insulin sensitivity.
The method is valuable for research, but it is complex and resource-intensive.
Various indirect markers are therefore used in other settings. They can be useful, but they are not fully interchangeable with a direct assessment of insulin sensitivity.
What Do We Know Today?
Insulin resistance does not mean that insulin has stopped working.
It describes reduced sensitivity to particular actions of insulin, which can manifest differently in different tissues.
The body can compensate for a time by increasing insulin secretion. This is one reason insulin resistance can exist before blood glucose becomes persistently elevated.
We also know that its development cannot be reduced to one food, one dietary component, or one cellular mechanism.
The athlete’s paradox clearly illustrates why context matters.
The same apparent feature—an increased amount of lipid within muscle cells—can be seen with both high and low insulin sensitivity.
The difference lies in the underlying biology.
That is precisely what makes insulin resistance more interesting—and more complex—than the simple claim that the body no longer “responds to insulin.”
References
- Accili D, Deng Z, Liu Q. Insulin resistance in type 2 diabetes mellitus. Nature Reviews Endocrinology. 2025;21(7):413–426. DOI: 10.1038/s41574-025-01114-y.
- Petersen MC, Shulman GI. Mechanisms of Insulin Action and Insulin Resistance. Physiological Reviews. 2018;98(4):2133–2223. DOI: 10.1152/physrev.00063.2017.
- Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. Journal of Clinical Investigation. 2016;126(1):12–22. DOI: 10.1172/JCI77812.
- Goodpaster BH, He J, Watkins S, Kelley DE. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. The Journal of Clinical Endocrinology & Metabolism. 2001;86(12):5755–5761. DOI: 10.1210/jcem.86.12.8075.
- Mezincescu AM, Rudd AE, Cheyne L, et al. Comparison of intramyocellular lipid metabolism in patients with diabetes and male athletes. Nature Communications. 2024;15(1):3690. DOI: 10.1038/s41467-024-47843-y.
- Tam CS, Xie W, Johnson WD, Cefalu WT, Redman LM, Ravussin E. Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care. 2012;35(7):1605–1610. DOI: 10.2337/dc11-2339.
